Request Free Sample ×
Liquid Biopsy Market Research Report - Global Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Liquid Biopsy Market

ID: MRFR/HC/0239-CR
171 Pages
Rahul Gotadki
Last Updated: May 11, 2026

Marktforschungsbericht zur Flüssigbiopsie: Größe, Anteil, Trendanalyse nach Anwendungen (Krebsdiagnose, Behandlungsüberwachung, Rückfallüberwachung, klinische Studien, Forschungsanwendungen), nach Probenart (Blut, Urin, Speichel, Pleuraflüssigkeit, Liquor cerebrospinalis), nach Technologie (Next Generation Sequencing, digitale PCR, Mikrofluidik, Exosomenisolierung, zirkulierende Tumorzellen), nach Endverwendung (Krankenhäuser, Diagnoselabore, Forschungsinstitute, Pharmaunternehmen) und nach Region (Nordamerika, Europa, Südamerika, Asien-Pazifik, Naher Osten und Afrika) - Wachstumsausblick & Branchenprognose 2025 bis 2035

Teilen
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Liquid Biopsy Market Infographic
Purchase Options
Compare License
Zusammenfassung Inhaltsverzeichnis Segmentierung Methodik PDF herunterladen
  1. 1 SUMMARY
    1. 1.1 Market Overview
    2. 1.2 Key Findings
    3. 1.3 Market Segmentation
    4. 1.4 Competitive Landscape
    5. 1.5 Challenges and Opportunities
    6. 1.6 Future Outlook
  2. 2 MARKET INTRODUCTION
    1. 2.1 Definition
    2. 2.2 Scope of the Study
      1. 2.2.1 Research Objective
      2. 2.2.2 Assumptions
      3. 2.2.3 Limitations
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 Overview
    2. 3.2 Data Mining
    3. 3.3 Secondary Research
    4. 3.4 Primary Research
      1. 3.4.1 Primary Interviews and Information Gathering Process
      2. 3.4.2 Breakdown of Key Respondents
    5. 3.5 Forecasting Model
    6. 3.6 Market Size Estimation
      1. 3.6.1 Bottom-Up Approach
      2. 3.6.2 Top-Down Approach
    7. 3.7 Data Triangulation
    8. 3.8 Validation
  4. 4 MARKET DYNAMICS
    1. 4.1 Overview
    2. 4.2 Drivers
    3. 4.3 Restraints
    4. 4.4 Opportunities
  5. 5 MARKET FACTOR ANALYSIS
    1. 5.1 Value Chain Analysis
    2. 5.2 Porter's Five Forces Analysis
      1. 5.2.1 Bargaining Power of Suppliers
      2. 5.2.2 Bargaining Power of Buyers
      3. 5.2.3 Threat of New Entrants
      4. 5.2.4 Threat of Substitute Products
      5. 5.2.5 Intensity of Rivalry
    3. 5.3 COVID-19 Impact Analysis
      1. 5.3.1 Market Impact Analysis
      2. 5.3.2 Regional Impact
      3. 5.3.3 Opportunity and Threat Analysis
  6. 6 LIQUID BIOPSY MARKET, BY APPLICATION (USD MILLION)
    1. 6.1 Cancer Diagnosis
    2. 6.2 Treatment Monitoring
    3. 6.3 Relapse Monitoring
    4. 6.4 Clinical Trials
    5. 6.5 Research Applications
  7. 7 LIQUID BIOPSY MARKET, BY SAMPLE TYPE (MILLION USD)
    1. 7.1 Blood
    2. 7.2 Urine
    3. 7.3 Saliva
    4. 7.4 Pleural Fluid
    5. 7.5 Cerebrospinal Fluid
  8. 8 LIQUID BIOPSY MARKET, BY TECHNOLOGY (MILLION USD)
    1. 8.1 Next-Generation Sequencing
    2. 8.2 Digital PCR
    3. 8.3 Microfluidics
    4. 8.4 Exosome Isolation
    5. 8.5 Circulating Tumor Cells
  9. 9 LIQUID BIOPSY MARKET, BY END-USE (MILLION USD)
    1. 9.1 Hospitals
    2. 9.2 Diagnostic Laboratories
    3. 9.3 Research Institutes
    4. 9.4 Pharmaceutical Companies
  10. 10 LIQUID BIOPSY MARKET, BY REGION (MILLION USD)
    1. 10.1 North America
      1. 10.1.1 USA
      2. 10.1.2 Canada
    2. 10.2 Europe
      1. 10.2.1 Germany
      2. 10.2.2 United Kingdom
      3. 10.2.3 France
      4. 10.2.4 Russia
      5. 10.2.5 Italy
      6. 10.2.6 Spain
      7. 10.2.7 Rest of Europe
    3. 10.3 Asia-Pacific
      1. 10.3.1 China
      2. 10.3.2 India
      3. 10.3.3 Japan
      4. 10.3.4 South Korea
      5. 10.3.5 Malaysia
      6. 10.3.6 Thailand
      7. 10.3.7 Indonesia
      8. 10.3.8 Rest of Asia-Pacific
    4. 10.4 South America
      1. 10.4.1 Brazil
      2. 10.4.2 Mexico
      3. 10.4.3 Argentina
      4. 10.4.4 Rest of South America
    5. 10.5 MEA
      1. 10.5.1 GCC Countries
      2. 10.5.2 South Africa
      3. 10.5.3 Rest of MEA
  11. 11 COMPETITIVE LANDSCAPE
    1. 11.1 Overview
    2. 11.2 Competitive Analysis
    3. 11.3 Market Share Analysis
    4. 11.4 Key Growth Strategies in the Liquid Biopsy Market
    5. 11.5 Competitive Benchmarking
    6. 11.6 Leading Players in the Number of Developments in the Liquid Biopsy Market
    7. 11.7 Key Developments and Growth Strategies
      1. 11.7.1 New Product/Service Launches
      2. 11.7.2 Mergers and Acquisitions
      3. 11.7.3 Joint Ventures
    8. 11.8 Key Players' Financial Matrix
      1. 11.8.1 Revenue and Operating Income
      2. 11.8.2 Key Players' R&D Expenditure 2023
  12. 12 COMPANY PROFILES
    1. 12.1 GRAIL
      1. 12.1.1 Financial Overview
      2. 12.1.3 Key Developments
      3. 12.1.4 SWOT Analysis
      4. 12.1.5 Key Strategies
    2. 12.1.2.Products Offered
    3. 12.2 Natera
      1. 12.2.1 Financial Overview
      2. 12.2.2 Products Offered
      3. 12.2.3 Key Developments
      4. 12.2.4 SWOT Analysis
      5. 12.2.5 Key Strategies
    4. 12.3 Foundation Medicine
      1. 12.3.1 Financial Overview
      2. 12.3.2 Products Offered
      3. 12.3.3 Key Developments
      4. 12.3.4 SWOT Analysis
      5. 12.3.5 Key Strategies
    5. 12.4 Exact Sciences
      1. 12.4.1 Financial Overview
      2. 12.4.2 Products Offered
      3. 12.4.3 Key Developments
      4. 12.4.4 SWOT Analysis
      5. 12.4.5 Key Strategies
    6. 12.5 Thermo Fisher Scientific
      1. 12.5.1 Financial Overview
      2. 12.5.2 Products Offered
      3. 12.5.3 Key Developments
      4. 12.5.4 SWOT Analysis
      5. 12.5.5 Key Strategies
    7. 12.6 Avantor
      1. 12.6.1 Financial Overview
      2. 12.6.2 Products Offered
      3. 12.6.3 Key Developments
      4. 12.6.4 SWOT Analysis
      5. 12.6.5 Key Strategies
    8. 12.7 ArcherDX
      1. 12.7.1 Financial Overview
      2. 12.7.2 Products Offered
      3. 12.7.3 Key Developments
      4. 12.7.4 SWOT Analysis
      5. 12.7.5 Key Strategies
    9. 12.8 Roche
      1. 12.8.1 Financial Overview
      2. 12.8.2 Products Offered
      3. 12.8.3 Key Developments
      4. 12.8.4 SWOT Analysis
      5. 12.8.5 Key Strategies
    10. 12.9 Medpace
      1. 12.9.1 Financial Overview
      2. 12.9.2 Products Offered
      3. 12.9.3 Key Developments
      4. 12.9.4 SWOT Analysis
      5. 12.9.5 Key Strategies
    11. 12.10 Illumina
      1. 12.10.1 Financial Overview
      2. 12.10.2 Products Offered
      3. 12.10.3 Key Developments
      4. 12.10.4 SWOT Analysis
      5. 12.10.5 Key Strategies
    12. 12.11 Guardant Health
      1. 12.11.1 Financial Overview
      2. 12.11.2 Products Offered
      3. 12.11.3 Key Developments
      4. 12.11.4 SWOT Analysis
      5. 12.11.5 Key Strategies
    13. 12.12 Qiagen
      1. 12.12.1 Financial Overview
      2. 12.12.2 Products Offered
      3. 12.12.3 Key Developments
      4. 12.12.4 SWOT Analysis
      5. 12.12.5 Key Strategies
    14. 12.13 Freenome
      1. 12.13.1 Financial Overview
      2. 12.13.2 Products Offered
      3. 12.13.3 Key Developments
      4. 12.13.4 SWOT Analysis
      5. 12.13.5 Key Strategies
    15. 12.14 Biocept
      1. 12.14.1 Financial Overview
      2. 12.14.2 Products Offered
      3. 12.14.3 Key Developments
      4. 12.14.4 SWOT Analysis
      5. 12.14.5 Key Strategies
  13. 13 APPENDIX
    1. 13.1 References
    2. 13.2 Related Reports TABLE LIST
    3. TABLE
  14. 1 LIST OF ASSUMPTIONS
    1. TABLE
  15. 2 ESTIMATED SIZE OF THE NORTH AMERICA LIQUID BIOPSY MARKET FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
    1. TABLE
  16. 3 ESTIMATED SIZE AND FORECAST FOR NORTH AMERICA LIQUID BIOPSY, BY SAMPLE TYPE, 2019–2035 (USD BILLION)
    1. TABLE
  17. 4 ESTIMATED SIZE AND FORECAST FOR NORTH AMERICA LIQUID BIOPSY, BY TECHNOLOGY, 2019–2035 (USD BILLION)
    1. TABLE
  18. 5 ESTIMATED SIZE AND FORECAST FOR NORTH AMERICA LIQUID BIOPSY, BY END USE, 2019–2035 (USD BILLION)
    1. TABLE
  19. 6 ESTIMATED SIZE AND FORECAST, BY REGION, 2019–2035 (USD BILLION)
    1. TABLE
  20. 7 ESTIMATED MARKET SIZE FOR LIQUID BIOPSY IN THE US, BY APPLICATION, 2019–2035 (USD BILLION)
    1. TABLE
  21. 8 ESTIMATED MARKET SIZE FOR LIQUID BIOPSY IN THE US, BY SAMPLE TYPE,Table
  22. 9 Estimates and forecasts of the market size for liquid biopsy in the USA, by technology, 2019–2035 (billion USD)
    1. Table
  23. 10 Forecast, by end use, 2019–2035 (billion USD)
    1. Table
  24. 11 Estimates and forecasts of the market size for liquid biopsy in the USA, by region, 2019–2035 (billion USD)
    1. Table
  25. 12 Estimates and forecasts of the market size for liquid biopsy in Canada, by application, 2019–2035 (billion USD)
    1. Table
  26. 13 Estimates and forecasts of the market size for liquid biopsy in Canada, by sample type, 2019–2035 (USD billion)
    1. Table
  27. 14 Forecast, by technology, 2019–2035 (USD billion)
    1. Table
  28. 15 Estimates and forecasts of the market size for liquid biopsy in Canada, by end use, 2019–2035 (USD billion)
    1. Table
  29. 16 Estimates and forecasts of the market size for liquid biopsy in Canada, by region, 2019–2035 (USD billion)
    1. Table
  30. 17 Estimates and forecasts of the market size for liquid biopsy
    1. Table
  31. 18 Forecast by sample type, 2019–2035 (billion USD)
    1. Table
  32. 19 Estimates and forecast of the market size for liquid biopsy in Europe by technology, 2019–2035 (billion USD)
    1. Table
  33. 20 Estimates and forecast of the market size for liquid biopsy in Europe by end use, 2019–2035 (billion USD)
    1. Table
  34. 21 Estimates and forecast of the market size for liquid biopsy in Europe by region, 2019–2035 (billion USD)
    1. Table
  35. 22 Forecast, by application, 2019–2035 (billion USD)
    1. Table
  36. 23 Estimated size and forecast for liquid biopsy in Germany, by sample type, 2019–2035 (billion USD)
    1. Table
  37. 24 Estimated size and forecast for liquid biopsy in Germany, by technology, 2019–2035 (billion USD)
    1. Table
  38. 25 Estimated size and forecast for liquid biopsy in Germany, by end use, 2019–2035 (billion USD)
    1. Table
  39. 26 Estimated size and forecast, by REGION, 2019–2035 (USD BILLION)
    1. TABLE
  40. 27 ESTIMATES AND FORECASTS OF THE UK LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2019–2035 (USD BILLION)
    1. TABLE
  41. 28 ESTIMATES AND FORECASTS OF THE UK LIQUID BIOPSY MARKET SIZE, BY SAMPLE TYPE, 2019–2035 (USD BILLION)
    1. TABLE
  42. 29 ESTIMATES AND FORECASTS OF THE UK LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2019–2035 (USD BILLION)
    1. TABLE
  43. 30 FORECAST, BY END USE,
    1. Table
  44. 31 UK liquid biopsy market size estimates and forecasts, by region, 2019–2035 (USD billion)
    1. Table
  45. 32 France liquid biopsy market size estimates and forecasts, by application, 2019–2035 (USD billion)
    1. Table
  46. 33 France liquid biopsy market size estimates and forecasts, by sample type, 2019–2035 (USD billion)
    1. Table
  47. 34 Forecast, by technology, 2019–2035 (USD billion)
  48. 35.Market size estimates and forecasts for liquid biopsy in France, by end use, 2019–2035 (USD billion)
    1. Table
  49. 36 Market size estimates and forecasts for liquid biopsy in France, by region, 2019–2035 (USD billion)
    1. Table
  50. 37 Market size estimates and forecasts for liquid biopsy in Russia, by application, 2019–2035 (USD billion)
    1. Table
  51. 38 Forecast, by sample type, 2019–2035 (USD billion)
    1. Table
  52. 39 Market size estimates and forecasts for Liquid Biopsy in Russia, by Technology, 2019–2035 (USD Billion)
    1. Table
  53. 40 Estimates and Forecast of the Market Size for Liquid Biopsy in Russia, by End Use, 2019–2035 (USD Billion)
    1. Table
  54. 41 Estimates and Forecast of the Market Size for Liquid Biopsy in Russia, by Region, 2019–2035 (USD Billion)
    1. Table
  55. 42 Forecast, by Application, 2019–2035 (USD Billion)
    1. Table
  56. 43 Estimates and Forecast of the Market Size for Liquid Biopsy in Italy, by Sample Type
    1. Table
  57. 44 Estimates and forecasts of the market size for liquid biopsy in Italy, by technology, 2019–2035 (billion USD)
    1. Table
  58. 45 Estimates and forecasts of the market size for liquid biopsy in Italy, by end use, 2019–2035 (billion USD)
    1. Table
  59. 46 Forecast, by region, 2019–2035 (billion USD)
    1. Table
  60. 47 Estimates and forecasts of the market size for liquid biopsy in Spain, by application, 2019–2035 (billion USD)
    1. Table
  61. 48 Market size estimates and forecasts for liquid biopsy in Spain, by sample type, 2019–2035 (USD billion)
    1. Table
  62. 49 Market size estimates and forecasts for liquid biopsy in Spain, by technology, 2019–2035 (USD billion)
    1. Table
  63. 50 Forecast, by end use, 2019–2035 (USD billion)
    1. Table
  64. 51 Market size estimates and forecasts for liquid biopsy in Spain, by region, 2019–2035 (USD billion)
    1. Table
  65. 52 Market size estimates and forecasts for liquid biopsy
    1. Table
  66. 53 Estimates and forecasts of the market size for liquid biopsy in the rest of Europe, by application, 2019–2035 (billion USD).
    1. Table
  67. 54 Forecast, by technology, 2019–2035 (billion USD).
    1. Table
  68. 55 Estimates and forecasts of the market size for liquid biopsy in the rest of Europe, by end use, 2019–2035 (billion USD).
    1. Table
  69. 56 Estimates and forecasts of the market size for liquid biopsy in the rest of Europe, by regional.
    1. Table
  70. 57 Estimates and forecasts of the market size for liquid biopsy in the APAC region, by application, 2019–2035 (billion USD)
    1. Table
  71. 58 Forecast, by sample type, 2019–2035 (billion USD)
    1. Table
  72. 59 Estimates and forecasts of the market size for liquid biopsy in the Asia-Pac region, by technology, 2019–2035 (billion USD)
    1. Table
  73. 60 Estimates and forecasts of the market size for liquid biopsy in the Asia-Pac region, by end use, 2019–2035 (billion USD)Table
  74. 61 Estimates and forecasts of the market size for liquid biopsy in the Asia-Pac region, by region, 2019–2035 (billion USD)
    1. Table
  75. 62 Forecast, by application, 2019–2035 (billion USD)
    1. Table
  76. 63 Estimates and forecasts of the market size for liquid biopsy in China, by sample type, 2019–2035 (billion USD)
    1. Table
  77. 64 Estimates and forecasts of the market size for liquid biopsy in China, by technology, 2019–2035 (billion USD)
    1. Table
  78. 65 Estimates and forecasts of the market size for liquid biopsy in China, by end use, 2019–2035 (USD billion)
    1. Table
  79. 66 Forecast, by region, 2019–2035 (USD billion)
    1. Table
  80. 67 Estimates and forecasts of the market size for liquid biopsy in India, by application, 2019–2035 (USD billion)
    1. Table
  81. 68 Estimates and forecasts of the market size for liquid biopsy in India, by sample type, 2019–2035 (USD billion)
    1. Table
  82. 69 Estimates and forecasts of the market size for Liquid Biopsy in India, by Technology, 2019–2035 (USD Billion)
    1. Table
  83. 70 Forecast, by End Use, 2019–2035 (USD Billion)
    1. Table
  84. 71 Estimates and Forecast of the Market Size for Liquid Biopsy in India, by Region, 2019–2035 (USD Billion)
    1. Table
  85. 72 Estimates and Forecast of the Market Size for Liquid Biopsy in Japan, by Application, 2019–2035 (USD Billion)
    1. Table
  86. 73 Estimates and Forecast of the Market Size for Liquid Biopsy in Japan, by Sample Type
    1. Table
  87. 74 Forecast by Technology, 2019–2035 (USD Billion)
    1. Table
  88. 75 Estimates and Forecast of the Market Size for Liquid Biopsy in Japan, by End Use, 2019–2035 (USD Billion)
    1. Table
  89. 76 Estimates and Forecast of the Market Size for Liquid Biopsy in Japan, by Region, 2019–2035 (USD Billion)
    1. Table
  90. 77 Estimates and Forecast of the Market Size for Liquid Biopsy in South Korea, by Application, 2019–2035 (USD Billion)
    1. Table
  91. 78 Forecast by Sample Type, 2019–2035 (USD Billion)
    1. Table
  92. 79 Estimates and Forecast of the Market Size for Liquid Biopsy in South Korea by Technology, 2019–2035 (USD Billion)
    1. Table
  93. 80 Estimates and Forecast of the Market Size for Liquid Biopsy in South Korea by End Use, 2019–2035 (USD Billion)
    1. Table
  94. 81 Estimates and Forecast of the Market Size for Liquid Biopsy in South Korea by Region, 2019–2035 (USD Billion)
    1. Table
  95. 82 Forecast by Application
    1. Table
  96. 83 Estimates and forecasts of the market size for liquid biopsy in Malaysia, by sample type, 2019–2035 (billion USD)
    1. Table
  97. 84 Estimates and forecasts of the market size for liquid biopsy in Malaysia, by technology, 2019–2035 (billion USD)
    1. Table
  98. 85 Estimates and forecasts of the market size for liquid biopsy in Malaysia, by end use, 2019–2035 (billion USD)
    1. Table
  99. 86 Forecast, by region, 2019–2035 (billion USD)
  100. 87.Market size estimates and forecasts for liquid biopsy in Thailand, by application, 2019–2035 (USD billion)
    1. Table
  101. 88 Market size estimates and forecasts for liquid biopsy in Thailand, by sample type, 2019–2035 (USD billion)
    1. Table
  102. 89 Market size estimates and forecasts for liquid biopsy in Thailand, by technology, 2019–2035 (USD billion)
    1. Table
  103. 90 Forecast, by end use, 2019–2035 (USD billion)
    1. Table
  104. 91 Market size estimates and forecasts for liquid biopsy
    1. Table
  105. 92 Estimates and forecasts of the market size for liquid biopsy in Thailand, by region, 2019–2035 (USD billion).
    1. Table
  106. 93 Estimates and forecasts of the market size for liquid biopsy in Indonesia, by application, 2019–2035 (USD billion).
    1. Table
  107. 94 Forecast, by technology, 2019–2035 (USD billion).
    1. Table
  108. 95 Estimates and forecasts of the market size for liquid biopsy in Indonesia, by end use.
    1. Table
  109. 96 Market size estimates and forecasts for liquid biopsy in Indonesia, by region, 2019–2035 (USD billion).
    1. Table
  110. 97 Market size estimates and forecasts for liquid biopsy in the rest of Asia Pacific, by application, 2019–2035 (USD billion).
    1. Table
  111. 98 Forecast, by sample type, 2019–2035 (USD billion).
    1. Table
  112. 99 Market size estimates and forecasts for liquid biopsy in the rest of Asia Pacific, by technology, 2019–2035. (USD billion)
    1. TABLE
  113. 100 Market size estimates and forecasts for liquid biopsy in the rest of APAC, by end use, 2019–2035 (USD billion)
    1. TABLE
  114. 101 Market size estimates and forecasts for liquid biopsy in the rest of APAC, by region, 2019–2035 (USD billion)
    1. TABLE
  115. 102 Forecast, by application, 2019–2035 (USD billion)
    1. TABLE
  116. 103 Market size estimates and forecasts for liquid biopsy in South America, by sample type, 2019–2035 (USD billion)
    1. Table
  117. 104 Estimates and forecasts of the market size for liquid biopsy in South America, by technology, 2019–2035 (USD billion)
    1. Table
  118. 105 Estimates and forecasts of the market size for liquid biopsy in South America, by end use, 2019–2035 (USD billion)
    1. Table
  119. 106 Forecast, by region, 2019–2035 (USD billion)
    1. Table
  120. 107 Estimates and forecasts of the market size for liquid biopsy in Brazil, by application, 2019–2035 (USD billion)
    1. Table
  121. 108 Estimates and Market size forecast for liquid biopsy in Brazil, by sample type, 2019–2035 (USD billion)
    1. Table
  122. 109 Estimates and forecast of market size for liquid biopsy in Brazil, by technology, 2019–2035 (USD billion)
    1. Table
  123. 110 Forecast, by end use, 2019–2035 (USD billion)
    1. Table
  124. 111 Market size forecast for liquid biopsy in Brazil, by region, 2019–2035 (USD billion)
    1. Table
  125. 112.Market size estimates and forecasts for liquid biopsy in Mexico, by application, 2019–2035 (USD billion)
    1. Table
  126. 113 Market size estimates and forecasts for liquid biopsy in Mexico, by sample type, 2019–2035 (USD billion)
    1. Table
  127. 114 Forecast, by technology, 2019–2035 (USD billion)
    1. Table
  128. 115 Market size estimates and forecasts for liquid biopsy in Mexico, by end use, 2019–2035 (USD billion)
    1. Table
  129. 116 Market size estimates and forecasts for Liquid Biopsy in Mexico, by Region, 2019–2035 (USD Billion)
    1. Table
  130. 117 Estimates and Forecast of the Market Size for Liquid Biopsy in Argentina, by Application, 2019–2035 (USD Billion)
    1. Table
  131. 118 Forecast, by Sample Type, 2019–2035 (USD Billion)
    1. Table
  132. 119 Estimates and Forecast of the Market Size for Liquid Biopsy in Argentina, by Technology, 2019–2035 (USD Billion)
    1. Table
  133. 120 Estimates and Forecast of the Market Size for Liquid Biopsy in Argentina, by END USE, 2019–2035 (USD BILLION)
    1. TABLE
  134. 121 MARKET SIZE ESTIMATES AND FORECASTS FOR LIQUID BIOPSY IN ARGENTINA, BY REGION, 2019–2035 (USD BILLION)
    1. TABLE
  135. 122 FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
    1. TABLE
  136. 123 MARKET SIZE ESTIMATES AND FORECASTS FOR LIQUID BIOPSY IN THE REST OF SOUTH AMERICA, BY SAMPLE TYPE, 2019–2035 (USD BILLION)
    1. TABLE
  137. 124 MARKET SIZE ESTIMATES AND FORECASTS FOR LIQUID BIOPSY IN THE REST OF SOUTH AMERICA, BY TECHNOLOGY,
    1. Table
  138. 125 Estimates and forecasts of the liquid biopsy market size in the rest of South America, by end use, 2019–2035 (USD billion)
    1. Table
  139. 126 Forecast, by region, 2019–2035 (USD billion)
    1. Table
  140. 127 Estimates and forecasts of the MEA market size for liquid biopsy, by application, 2019–2035 (USD billion)
    1. Table
  141. 128 Estimates and forecasts of the MEA market size for liquid biopsy, by sample type, 2019–2035 (USD billion)
    1. TABLE
  142. 129 MEA LIQUID BIOPSY MARKET SIZE ESTIMATES AND FORECASTS, BY TECHNOLOGY, 2019–2035 (USD BILLION)
    1. TABLE
  143. 130 FORECAST, BY END USE, 2019–2035 (USD BILLION)
    1. TABLE
  144. 131 MEA LIQUID BIOPSY MARKET SIZE ESTIMATES AND FORECASTS, BY REGION, 2019–2035 (USD BILLION)
    1. TABLE
  145. 132 GCC COUNTRIES' LIQUID BIOPSY MARKET SIZE ESTIMATES AND FORECASTS, BY APPLICATION, 2019–2035 (USD BILLION)
    1. TABLE
  146. 133 ESTIMATES AND FORECASTS OF Market size for liquid biopsy in GCC countries, by sample type, 2019–2035 (USD billion)
    1. Table
  147. 134 Forecast, by technology, 2019–2035 (USD billion)
    1. Table
  148. 135 Estimates and forecast of the market size for liquid biopsy in GCC countries, by end use, 2019–2035 (USD billion)
    1. Table
  149. 136 Estimates and forecast of the market size for liquid biopsy in GCC countries, by region, 2019–2035 (USD billion)
    1. Table
  150. 137 Estimates and forecast of Market size for liquid biopsy in South Africa, by application,Table
  151. 138 Forecast by Sample Type, 2019–2035 (USD Billion)
    1. Table
  152. 139 Estimates and Forecast of the Market Size for Liquid Biopsy in South Africa, by Technology, 2019–2035 (USD Billion)
    1. Table
  153. 140 Estimates and Forecast of the Market Size for Liquid Biopsy in South Africa, by End Use, 2019–2035 (USD Billion)
    1. Table
  154. 141 Estimates and Forecast of the Market Size for Liquid Biopsy in South Africa, by Region, 2019–2035 (USD billion)
    1. TABLE
  155. 142 FORECAST, BY APPLICATION, 2019–2035 (USD billion)
    1. TABLE
  156. 143 ESTIMATES AND FORECAST OF THE MARKET SIZE FOR LIQUID BIOPSY IN THE REST OF MEA, BY SAMPLE TYPE, 2019–2035 (USD billion)
    1. TABLE
  157. 144 ESTIMATES AND FORECAST OF THE MARKET SIZE FOR LIQUID BIOPSY IN THE REST OF MEA, BY TECHNOLOGY, 2019–2035 (USD billion)
    1. TABLE
  158. 145 ESTIMATES AND FORECAST OF THE MARKET SIZE FOR LIQUID BIOPSY IN THE REST OF MEA, BY END USE, 2019–2035 (USD billion)
    1. TABLE
  159. 146 FORECAST BY REGION, 2019–2035 (USD BILLION)
    1. TABLE
  160. 147 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/PERMITTING
    1. TABLE
  161. 148 ACQUISITION/PARTNERSHIP LIST OF FIGURES
    1. FIGURE
  162. 1 MARKET OVERVIEW
    1. FIGURE
  163. 2 NORTH AMERICA LIQUID BIOPSY MARKET ANALYSIS
    1. FIGURE
  164. 3 US LIQUID BIOPSY MARKET ANALYSIS BY APPLICATION
    1. FIGURE
  165. 4 US LIQUID BIOPSY MARKET ANALYSIS BY SAMPLE TYPE BIOPSY MARKET ANALYSIS BY TECHNOLOGY
    1. FIGURE
  166. 6 US LIQUID BIOPSY MARKET ANALYSIS BY END USE
    1. FIGURE
  167. 7 US Market Analysis for Liquid Biopsy by Region
    1. Figure
  168. 8 Canadian Market Analysis for Liquid Biopsy by Application
    1. Figure
  169. 9 Canadian Market Analysis for Liquid Biopsy by Sample Type
    1. Figure
  170. 10 Canadian Market Analysis for Liquid Biopsy by Technology
    1. Figure
  171. 11 Canadian Market Analysis for Liquid Biopsy by End Use
    1. Figure
  172. 12 Canadian Market Analysis for Liquid Biopsy by Region
    1. Figure
  173. 13 European Market Analysis for Liquid Biopsy
    1. Figure
  174. 14 Germany – Liquid Biopsy Detection – Analysis by Application
    1. FIGURE
  175. 15 GERMANY – LIQUID BIOPSY DETECTION – ANALYSIS BY SAMPLE TYPE
    1. FIGURE
  176. 16 GERMANY – LIQUID BIOPSY DETECTION – ANALYSIS BY TECHNOLOGY
    1. FIGURE
  177. 17 GERMANY – LIQUID BIOPSY DETECTION – ANALYSIS BY END USE
    1. FIGURE
  178. 18 GERMANY – LIQUID BIOPSY DETECTION – ANALYSIS BY REGION
    1. FIGURE
  179. 19 UK – LIQUID BIOPSY DETECTION – ANALYSIS BY APPLICATION
    1. FIGURE
  180. 20 UK – LIQUID BIOPSY DETECTION – ANALYSIS BY SAMPLE TYPE
    1. FIGURE
  181. 21 UK – LIQUID BIOPSY DETECTION – Biopsy Market Analysis by End Use
    1. Figure
  182. 23 UK: Liquid Biopsy Market Analysis by Region
    1. Figure
  183. 24 France: Liquid Biopsy Market Analysis by Application
    1. Figure
  184. 25 France: Liquid Biopsy Market Analysis by Sample Type
    1. Figure
  185. 26 France: Liquid Biopsy Market Analysis by Technology
    1. Figure
  186. 27 France: Liquid Biopsy Market Analysis by End Use
    1. Figure
  187. 28 France:Liquid Biopsy Market Analysis by Region
    1. Figure
  188. 29 Russia: Liquid Biopsy Market Analysis by Application
    1. Figure
  189. 30 Russia: Liquid Biopsy Market Analysis by Sample Type
    1. Figure
  190. 31 Market Analysis for Liquid Biopsy in Russia by Technology
    1. Figure
  191. 32 Market Analysis for Liquid Biopsy in Russia by End Use
    1. Figure
  192. 33 Market Analysis for Liquid Biopsy in Russia by Region
    1. Figure
  193. 34 Market Analysis for Liquid Biopsy in Italy by Application
    1. Figure
  194. 35 Market Analysis for Liquid Biopsy in Italy by SAMPLE TYPE
    1. FIGURE
  195. 36 MARKET ANALYSIS FOR LIQUID BIOPSY IN ITALY BY TECHNOLOGY
    1. FIGURE
  196. 37 MARKET ANALYSIS FOR LIQUID BIOPSY IN ITALY BY END-USE
    1. FIGURE
  197. 38 MARKET ANALYSIS FOR LIQUID BIOPSY IN ITALY BY REGION
    1. FIGURE
  198. 39 Market analysis for liquid biopsy in Spain by application
    1. Figure
  199. 40 Market analysis for liquid biopsy in Spain by sample type
    1. Figure
  200. 41 Market analysis for liquid biopsy in Spain by technology
    1. Figure
  201. 42 Market analysis for liquid biopsy in Spain by end-use
    1. Figure
  202. 43 Market analysis for liquid biopsy in Spain by region
    1. Figure
  203. 44 Market analysis for liquid biopsy in the rest of Europe by application
    1. Figure
  204. 45 Market analysis for liquid biopsy in the rest of Europe by sample type
    1. Figure
  205. 46 Market analysis for liquid biopsy in the rest of Europe by technology Figure EUROPE, Liquid Biopsy Market Analysis by End Use
    1. Figure
  206. 48 Rest of Europe, Liquid Biopsy Market Analysis by Region
    1. Figure
  207. 49 APAC, Liquid Biopsy Market Analysis
    1. Figure
  208. 50 China, Liquid Biopsy Market Analysis by Application
    1. Figure
  209. 51 China, Liquid Biopsy Market Analysis by Sample Type
    1. Figure
  210. 52 China, Liquid Biopsy Market Analysis by Technology
    1. Figure
  211. 53 China, Liquid Biopsy Market Analysis by End Use
    1. Figure
  212. 54 China, Liquid Biopsy Market Analysis by Region
  213. 55 INDIA, LIQUID BIOPSY MARKET ANALYSIS BY APPLICATION
    1. FIGURE
  214. 56 MARKET ANALYSIS FOR LIQUID BIOPSY IN INDIA BY SAMPLE TYPE
    1. FIGURE
  215. 57 MARKET ANALYSIS FOR LIQUID BIOPSY IN INDIA BY TECHNOLOGY
    1. FIGURE
  216. 58 MARKET ANALYSIS FOR LIQUID BIOPSY IN INDIA BY END USE
    1. FIGURE
  217. 59 MARKET ANALYSIS FOR LIQUID BIOPSY IN INDIA BY REGION
    1. FIGURE
  218. 60 MARKET ANALYSIS FOR LIQUID BIOPSY IN JAPAN BY APPLICATION
    1. FIGURE
  219. 61 MARKET ANALYSIS FOR LIQUID BIOPSY IN JAPAN BY SAMPLE TYPE
    1. FIGURE
  220. 62 MARKET ANALYSIS FOR LIQUID BIOPSY IN Japan by Technology
    1. Figure
  221. 63 Market Analysis for Liquid Biopsies in Japan by End Use
    1. Figure
  222. 64 Japanese Market Analysis for Liquid Biopsies by Region
    1. Figure
  223. 65 South Korean Market Analysis for Liquid Biopsies by Application
    1. Figure
  224. 66 South Korean Market Analysis for Liquid Biopsies by Sample Type
    1. Figure
  225. 67 South Korean Market Analysis for Liquid Biopsies by Technology
    1. Figure
  226. 68 South Korean Market Analysis for Liquid Biopsies by End Use
    1. Figure
  227. 69 South Korean Market Analysis for Liquid Biopsies by Region
    1. FIGURE
    2. 70.MALAYSIA MARKET ANALYSIS FOR LIQUID BIOPSY BY APPLICATION
    3. FIGURE
  228. 71 MALAYSIA MARKET ANALYSIS FOR LIQUID BIOPSY BY SAMPLE TYPE
    1. FIGURE
  229. 72 MARKET ANALYSIS FOR LIQUID BIOPSY IN MALAYSIA BY TECHNOLOGY
    1. FIGURE
  230. 73 MARKET ANALYSIS FOR LIQUID BIOPSY IN MALAYSIA BY END USE
    1. FIGURE
  231. 74 MARKET ANALYSIS FOR LIQUID BIOPSY IN MALAYSIA BY REGION
    1. FIGURE
  232. 75 MARKET ANALYSIS FOR LIQUID BIOPSY IN THAILAND BY APPLICATION
    1. FIGURE
  233. 76 MARKET ANALYSIS FOR LIQUID BIOPSY IN THAILAND BY SAMPLE TYPE
    1. FIGURE
  234. 77 MARKET ANALYSIS FOR LIQUID BIOPSY Market analysis for liquid biopsy in Thailand by technology (Figure 78). Market analysis for liquid biopsy in Thailand by end use (regional,
    1. Figure 80). Market analysis for liquid biopsy in Indonesia by application (Figure 81). Market analysis for liquid biopsy in Indonesia by sample type (Figure 82). Market analysis for liquid biopsy in Indonesia by technology (Figure 83). Market analysis for liquid biopsy in Indonesia by end use (Figure 84). Market analysis for liquid biopsy in Indonesia by region (Figure 85). Market analysis for liquid biopsy in REMAINING APAC AREA BY APPLICATION
    2. FIGURE
  235. 86 MARKET ANALYSIS FOR LIQUID BIOPSY IN THE REMAINING APAC AREA BY SAMPLE TYPE MARKET ANALYSIS BY TECHNOLOGY
    1. FIGURE
  236. 88 MARKET ANALYSIS FOR LIQUID BIOPSY IN THE REMAINING APAC AREA BY END-USE
    1. FIGURE
  237. 89 MARKET ANALYSIS FOR LIQUID BIOPSY IN THE REMAINING APAC AREA BY REGIONAL
    1. FIGURE
  238. 90 MARKET ANALYSIS FOR LIQUID BIOPSY IN SOUTH AMERICA
    1. FIGURE
  239. 91 MARKET ANALYSIS FOR LIQUID BIOPSY IN BRAZIL BY APPLICATION
    1. FIGURE
  240. 92 MARKET ANALYSIS FOR LIQUID BIOPSY IN BRAZIL BY SAMPLE TYPE
    1. FIGURE
  241. 93 Market analysis for liquid biopsy in Brazil by technology (Figure 94). Market analysis for liquid biopsy in Brazil by end use (Figure 96). Market analysis for liquid biopsy in Mexico by application (Figure 97). Market analysis for liquid biopsy in Mexico by sample type (Figure 98). Market analysis for liquid biopsy in Mexico by technology (Figure 99). Market analysis for liquid biopsy in Mexico by end use (Figure 100). Market analysis for liquid biopsy in Mexico by region (Figure 101). Market analysis for liquid biopsy in Argentina by application,
    1. Figure
  242. 102 Market analysis for liquid biopsy in Argentina by sample type, analysis by technology,
    1. Figure
  243. 104 Market analysis for liquid biopsy in Argentina by end use,
    1. Figure
  244. 105 Market analysis for liquid biopsy in Argentina by region,
    1. Figure
  245. 106 Market analysis for liquid biopsy in the rest of South America by application,
    1. Figure
  246. 107 Market analysis for liquid biopsy in the rest of South America by sample type,
    1. Figure
  247. 108 Market analysis for liquid biopsy in the rest of South America SOUTH AMERICA BY TECHNOLOGY
    1. FIGURE
  248. 109 MARKET ANALYSIS FOR LIQUID BIOPSY IN THE REST OF SOUTH AMERICA BY END USE
    1. FIGURE
  249. 110 MARKET FOR LIQUID BIOPSY IN THE REST OF SOUTH AMERICA ANALYSIS BY REGIONAL
    1. FIGURE
    2. 111.MEA Market Analysis for Liquid Biopsy
    3. Figure
  250. 112 Market Analysis for Liquid Biopsy in the GCC Countries by Application
    1. Figure
  251. 113 Market Analysis for Liquid Biopsy in the GCC Countries by Sample Type
    1. Figure
  252. 114 Market Analysis for Liquid Biopsy in the GCC Countries by Technology
    1. Figure
  253. 115 Market Analysis for Liquid Biopsy in the GCC Countries by End Use
    1. Figure
  254. 116 Market Analysis for Liquid Biopsy in the GCC Countries by Region
    1. Figure
  255. 117 Market Analysis for Liquid Biopsy in South Africa African liquid biopsy market analysis by sample type,
    1. Figure
  256. 119 South African liquid biopsy market analysis by technology,
    1. Figure
  257. 120 South African liquid biopsy market analysis by end use,
    1. Figure
  258. 121 South African liquid biopsy market analysis by region,
    1. Figure
  259. 122 Remaining MEA liquid biopsy market analysis by application,
    1. Figure
  260. 123 Remaining MEA liquid biopsy market analysis by sample type,
    1. Figure
  261. 124 Remaining MEA liquid

Market segmentation for liquid biopsies

  • Liquid biopsy market by application (USD billion, 2019–2035)

    • Cancer diagnosis

    • Treatment monitoring

    • Relapse monitoring

    • Clinical trials

    • Research applications

 

  • Liquid biopsy market by sample type (USD billion, 2019–2035)

    • blood

    • Urine

    • saliva

    • Pleural fluid

    • Cerebrospinal fluid

 

  • Liquid biopsy market by technology (USD billion, 2019–2035)

    • Next-generation sequencing

    • Digital PCR

    • Microfluidics

    • Exosome isolation

    • Circulating tumor cells

 

  • Liquid biopsy market by end-use application (USD billion, 2019–2035)

    • Hospitals

    • Diagnoselabore

    • Research institutes

    • pharmaceutical companies

 

  • Liquid Biopsy Market by Region (USD billion, 2019–2035)

    • North America

    • Europe

    • South America

    • Asia-Pacific

    • Middle East and Africa

 

Regional Market Outlook for Liquid Biopsies (USD billion, 2019–2035)

 

 

  • Outlook for North America (USD billion, 2019–2035)

    • Liquid Biopsy Market in North America by Application Type

      • Cancer diagnosis

      • Treatment monitoring

      • Relapse monitoring

      • Clinical trials

      • Research applications

    • Liquid Biopsy Market in North America by Sample Type

      • blood

      • Urine

      • saliva

      • Pleural fluid

      • Cerebrospinal fluid

    • North American Liquid Biopsy Market by Technology Type

      • Next-generation sequencing

      • Digital PCR

      • Microfluidics

      • Exosome isolation

      • Circulating tumor cells

    • North American liquid biopsy market by end use

      • Hospitals

      • Diagnoselabore

      • Research institutes

      • pharmaceutical companies

    • North American Liquid Biopsy Market by Regional Type

      • deer

      • You have

    • US Outlook (USD billion, 2019–2035)

    • US liquid biopsy market by application type

      • Cancer diagnosis

      • Treatment monitoring

      • Relapse monitoring

      • Clinical trials

      • Research applications

    • US liquid biopsy market by sample type

      • blood

      • Urine

      • saliva

      • Pleural fluid

      • Cerebrospinal fluid

    • US liquid biopsy market by technology type

      • Next-generation sequencing

      • Digital PCR

      • Microfluidics

      • Exosome isolation

      • Circulating tumor cells

    • US liquid biopsy market by end-use type

      • Hospitals

      • Diagnoselabore

      • Research institutes

      • pharmaceutical companies

    • CANADA Outlook (USD billion, 2019–2035)

    • CANADIAN Liquid Biopsy Market by Application Type

      • Cancer diagnosis

      • Treatment monitoring

      • Relapse monitoring

      • Clinical trials

      • Research applications

    • CANADIAN Liquid Biopsy Market by Sample Type

      • blood

      • Urine

      • saliva

      • Pleural fluid

      • Cerebrospinal fluid

    • CANADIAN Liquid Biopsy Market by Technology Type

      • Next-generation sequencing

      • Digital PCR

      • Microfluidics

      • Exosome isolation

      • Circulating tumor cells

    • CANADIAN liquid biopsy market by end-use type

      • Hospitals

      • Diagnoselabore

      • Research institutes

      • pharmaceutical companies

  • Outlook for Europe (USD billion, 2019–2035)

    • European liquid biopsy market by application type

      • Cancer diagnosis

      • Treatment monitoring

      • Relapse monitoring

      • Clinical trials

      • Research Applications

    • European liquid biopsy market by sample type

      • blood

      • Urine

      • saliva

      • Pleural fluid

      • Cerebrospinal fluid

    • European liquid biopsy market by technology type

      • Next-generation sequencing

      • Digital PCR

      • Microfluidics

      • Exosome isolation

      • Circulating tumor cells

    • European market for liquid biopsy by end-use type

      • Hospitals

      • Diagnoselabore

      • Research institutes

      • pharmaceutical companies

    • Europe: Liquid biopsy market by region

      • Germany

      • Great Britain

      • France

      • Russia

      • Italy

      • Spain

      • Rest of Europe

    • GERMANY: Outlook (USD billion, 2019–2035)

    • Liquid biopsy market in Germany by application type

      • Cancer diagnosis

      • Treatment monitoring

      • Relapse monitoring

      • Clinical trials

      • Research applications

    • Liquid biopsy market in Germany by sample type

      • blood

      • Urine

      • saliva

      • Pleural fluid

      • Cerebrospinal fluid liquid biopsy market in Germany by technology type

    • Liquid biopsy market in Germany by technology type

      • Next-generation sequencing

      • Digital PCR

      • Microfluidics

      • Exosome isolation

      • Circulating tumor cells

    • Liquid biopsy market in Germany by end use

      • Hospitals

      • Diagnoselabore

      • Research institutes

      • pharmaceutical companies

    • Outlook for Great Britain (USD billion, 2019–2035)

    • UK liquid biopsy market by application type

      • Cancer diagnosis

      • Treatment monitoring

      • Relapse monitoring

      • Clinical trials

      • Research applications

    • UK liquid biopsy market by sample type

      • blood

      • Urine

      • saliva

      • Pleural fluid

      • Cerebrospinal fluid

    • UK liquid biopsy market by technology type

      • Next-generation sequencing

      • Digital PCR

      • Microfluidics

      • Exosome isolation

      • Circulating tumor cells

    • UK liquid biopsy market by end use

      • Hospitals

      • Diagnoselabore

      • Research institutes

      • pharmaceutical companies

    • FRANKREICH: Ausblick (Mrd. USD, 2019–2035)

    • Flüssigbiopsie-Markt in Frankreich nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Flüssigbiopsie-Markt in Frankreich nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssigkeit

    • Flüssigbiopsie-Markt in Frankreich nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Flüssigbiopsie-Markt in Frankreich nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Ausblick für Russland (Mrd. USD, 2019–2035)

    • RUSSLAND: Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • RUSSLAND: Markt für Flüssigbiopsie nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssigkeit

    • RUSSLAND: Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • RUSSLAND: Markt für Flüssigbiopsie nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • ITALIE: Ausblick (USD) Milliarden, 2019–2035)

    • ITALIEN: Flüssigbiopsie-Markt nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • ITALIEN: Flüssigbiopsie-Markt nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssig

    • ITALIEN: Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • ITALIEN: Markt für Flüssigbiopsie nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • SPANIEN: Ausblick (Mrd. USD, 2019–2035)

    • Spanien: Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Spanien: Markt für Flüssigbiopsie nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssigbiopsie

    • Spanien: Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Spanien: Markt für Flüssigbiopsie nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Ausblick für das restliche Europa (USD) Milliarden, 2019–2035)

    • Markt für Flüssigbiopsie im übrigen Europa nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Markt für Flüssigbiopsie im übrigen Europa nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssig

    • Markt für Flüssigbiopsie im übrigen Europa nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie im übrigen Europa nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmazeutische Unternehmen

  • APAC-Ausblick (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie in der Region Asien-Pazifik nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Markt für Flüssigbiopsie in der Region Asien-Pazifik nach Stichprobe Typ

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit

    • Markt für Flüssigbiopsie in Asien-Pazifik nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie in Asien-Pazifik nach Endanwendung Typ

      • Krankenhäuser

      • Diagnostiklabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Markt für Flüssigbiopsie im asiatisch-pazifischen Raum nach Regionen

      • China

      • Indien

      • Japan

      • Südkorea

      • Malaysia

      • Thailand

      • Indonesien

      • Rest der asiatisch-pazifischen Region

    • Ausblick für China (USD) Milliarden, 2019–2035)

    • CHINA: Flüssigbiopsie-Markt nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • CHINA: Flüssigbiopsie-Markt nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssig

    • CHINA: Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • CHINA: Markt für Flüssigbiopsie nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Ausblick Indien (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie in Indien nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Markt für Flüssigbiopsie in Indien nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssig

    • Markt für Flüssigbiopsie in Indien nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie in Indien nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Ausblick Japan (Mrd. USD, 2019–2035)

    • Japanischer Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Japanischer Markt für Flüssigbiopsie nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssigbiopsie

    • Japanischer Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Japanischer Markt für Flüssigbiopsie nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Ausblick Südkorea (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie in Südkorea nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Markt für Flüssigbiopsie in Südkorea nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssigbiopsie

    • Markt für Flüssigbiopsie in Südkorea nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie in Südkorea nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmazeutische Unternehmen

    • MALAYSIA-Ausblick (Mrd. USD, 2019–2035)

    • MALAYSIA: Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • MALAYSIA: Markt für Flüssigbiopsie nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleura Flüssigkeit

      • Zerebrospinalflüssigkeit

    • MALAYSISCHER Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • MALAYSISCHER Markt für Flüssigbiopsie nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmazeutische Unternehmen

    • THAILAND: Prognose (Mrd. USD, 2019–2035)

    • THAILAND: Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • THAILAND: Markt für Flüssigbiopsie nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleura Flüssigkeit

      • Zerebrospinalflüssigkeit

    • Markt für Flüssigbiopsie in Thailand nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie in Thailand nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmazeutische Unternehmen

    • Indonesien: Prognose (Mrd. USD, 2019–2035)

    • Indonesien: Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Indonesien: Markt für Flüssigbiopsie nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleura Flüssigkeit

      • Zerebrospinalflüssigkeit

    • Indonesischer Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Indonesischer Markt für Flüssigbiopsie nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmazeutisch Unternehmen

    • Ausblick für den restlichen Asien-Pazifik-Raum (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie im restlichen Asien-Pazifik-Raum nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Markt für Flüssigbiopsie im restlichen Asien-Pazifik-Raum nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleura Flüssigkeit

      • Zerebrospinalflüssigkeit

    • RESTLICHER APAC-Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie im Rest der Region Asien-Pazifik nach Endverbrauchsart

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

  • Ausblick Südamerika (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie in Südamerika nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Markt für Flüssigbiopsie in Südamerika nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssigkeit

    • Markt für Flüssigbiopsie in Südamerika nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie in Südamerika nach Endanwendung

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Markt für Flüssigbiopsie in Südamerika nach Regionaler Typ

      • Brasilien

      • Mexiko

      • Argentinien

      • Restliches Südamerika

    • Brasilien-Ausblick (Mrd. USD, 2019–2035)

    • Brasilien: Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Brasilien: Markt für Flüssigbiopsie nach Proben Typ

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit

    • Brasilien: Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Brasilien: Markt für Flüssigbiopsie nach Endanwendung Typ

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Ausblick für Mexiko (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie in Mexiko nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Flüssigbiopsie in Mexiko Markt nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit

    • Mexiko: Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • Mexiko: Markt für Flüssigbiopsie nach Endanwendung Typ

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • ARGENTINIEN: Prognose (Mrd. USD, 2019–2035)

    • ARGENTINIEN: Markt für Flüssigbiopsie nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • ARGENTINIEN Markt für Flüssigbiopsie nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit

    • ARGENTINIEN: Markt für Flüssigbiopsie nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierende Tumorzellen

    • ARGENTINIEN: Markt für Flüssigbiopsie nach Endanwendung Typ

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Ausblick für den Rest von Südamerika (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie im Rest von Südamerika nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschung Anwendungen

    • Markt für Flüssigbiopsie im restlichen Südamerika nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit

    • Markt für Flüssigbiopsie im restlichen Südamerika nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosomenisolierung

      • Zirkulierender Tumor Zellen

    • Markt für Flüssigbiopsie in Südamerika nach Anwendungsgebiet

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

  • MEA-Ausblick (Mrd. USD, 2019–2035)

    • MEA-Markt für Flüssigbiopsie nach Anwendungsgebiet

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidive Überwachung

      • Klinische Studien

      • Forschungsanwendungen

    • MEA-Flüssigbiopsie-Markt nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Gehirn-Rückenmarks-Flüssigkeit

    • MEA-Flüssigbiopsie-Markt nach Technologietyp

      • Sequenzierung der nächsten Generation

      • Digitale PCR

      • Mikrofluidik

      • Exosom Isolierung

      • Zirkulierende Tumorzellen

    • Markt für Flüssigbiopsie im Nahen Osten und Afrika (MEA) nach Endverbrauchsart

      • Krankenhäuser

      • Diagnoselabore

      • Forschungsinstitute

      • Pharmaunternehmen

    • Markt für Flüssigbiopsie im Nahen Osten und Afrika (MEA) nach regionalem Typ

      • GCC-Länder

      • Südafrika

      • Rest der MEA-Länder

    • Ausblick für die GCC-Länder (Mrd. USD, 2019–2035)

    • Markt für Flüssigbiopsie in den GCC-Ländern nach Anwendungstyp

      • Krebsdiagnose

      • Behandlungsüberwachung

      • Rezidivüberwachung

      • Klinische Studien

      • Forschungsanwendungen

    • Markt für Flüssigbiopsie in den GCC-Ländern nach Probentyp

      • Blut

      • Urin

      • Speichel

      • Pleuraflüssigkeit

      • Zerebrospinalflüssigkeit Flüssigbiopsiemarkt in den GCC-Ländern nach Technologietyp

        • Sequenzierung der nächsten Generation

        • Digitale PCR

        • Mikrofluidik

        • Exosomenisolierung

        • Zirkulierende Tumorzellen

      • Flüssigbiopsiemarkt in den GCC-Ländern nach Endanwendung

        • Krankenhäuser

        • Diagnoselabore

        • Forschungsinstitute

        • Pharmaunternehmen

      • SÜD AFRIKA-Ausblick (Mrd. USD, 2019–2035)

      • Markt für Flüssigbiopsie in Südafrika nach Anwendungstyp

        • Krebsdiagnose

        • Behandlungsüberwachung

        • Rezidivüberwachung

        • Klinische Studien

        • Forschungsanwendungen

      • Markt für Flüssigbiopsie in Südafrika nach Probentyp

        • Blut

        • Urin

        • Speichel

        • Pleuraflüssigkeit

        • Zerebrospinalflüssigkeit Flüssigkeit

      • Markt für Flüssigbiopsie in Südafrika nach Technologietyp

        • Sequenzierung der nächsten Generation

        • Digitale PCR

        • Mikrofluidik

        • Exosomenisolierung

        • Zirkulierende Tumorzellen

      • Markt für Flüssigbiopsie in Südafrika nach Endanwendung

        • Krankenhäuser

        • Diagnoselabore

        • Forschungsinstitute

        • Pharmazeutische Unternehmen

      • Ausblick für den Rest des Nahen Ostens (Mrd. USD, 2019–2035)

      • Markt für Flüssigbiopsie im Rest des Nahen Ostens (MEA) nach Anwendungstyp

        • Krebsdiagnose

        • Behandlungsüberwachung

        • Rezidivüberwachung

        • Klinische Studien

        • Forschungsanwendungen

      • Markt für Flüssigbiopsie im Rest des Nahen Ostens (MEA) nach Probentyp

        • Blut

        • Urin

        • Speichel

        • Pleura Flüssigkeit

        • Zerebrospinalflüssigkeit

      • Markt für Flüssigbiopsie im restlichen Nahen Osten und Afrika nach Technologietyp

        • Sequenzierung der nächsten Generation

        • Digitale PCR

        • Mikrofluidik

        • Exosomenisolierung

        • Zirkulierende Tumorzellen

      • Markt für Flüssigbiopsie im restlichen Nahen Osten und Afrika nach Endanwendungsart

        • Krankenhäuser

        • Diagnoselabore

        • Forschungsinstitute

        • Pharmazeutische Unternehmen

Verwandte Berichte

Für diesen Markt sind keine regionalen Berichte verfügbar.

Für diesen Markt sind keine länderspezifischen Berichte verfügbar.

Customer Stories
Case Study Cover Image
Fallstudie

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓